A minimally invasive treatment for the two million heart failure patients who are too sick for medication
We give cardiologists a tool that lets the heart rest and heal without surgery
Life Science Entrepreneurs, Cardiologists, and Circulatory Support Experts
Procyrion receives $1.5 million Texas Emerging Technology Fund award.
Procyrion wins HTC's prestigious 2012 Goradia Innovation Prize.